Business Details
We have pioneered regenerative veterinary medicine since our formation in 2002. We were the first company in the United States to provide adipose-derived stem cell services to veterinarians. We hold exclusive licenses to over 70 patents covering worldwide veterinary rights for adipose-derived stem cells. We have treated over 16,000 animals with our proprietary cell therapy protocols. We published the first peer-reviewed blinded placebo-controlled multicenter study demonstrating significant improvement in canine hip osteoarthritis. We processed the first equine tendon injury case in January 2004, achieving a high return-to-performance rate.
We expanded our services to canine osteoarthritis and orthopedic soft tissue injuries in 2005. We maintain rigorous scientific standards through blinded controlled studies in both horses and dogs. We offer veterinarians personalized support from our veterinary, marketing, and customer service teams. We require no capital investment or equipment maintenance from our veterinary partners. We remain committed to improving animal lives through transparent, evidence-based regenerative treatments. We continue to lead the field with innovative products like PrecisePRP and Steminsure for long-term cell banking.
We expanded our services to canine osteoarthritis and orthopedic soft tissue injuries in 2005. We maintain rigorous scientific standards through blinded controlled studies in both horses and dogs. We offer veterinarians personalized support from our veterinary, marketing, and customer service teams. We require no capital investment or equipment maintenance from our veterinary partners. We remain committed to improving animal lives through transparent, evidence-based regenerative treatments. We continue to lead the field with innovative products like PrecisePRP and Steminsure for long-term cell banking.
Highlights and features
- We pioneered adipose stem cell services in 2002.
- We hold exclusive licenses to over 70 patents.
- We published blinded controlled studies proving treatment efficacy.
- We have treated over 16,000 animals successfully.
- We provide veterinarians personalized support without equipment costs.
Services
Regenerative Cell Therapy
Our regenerative cell therapy uses adipose-derived stem cells to treat arthritis, tendon, and ligament injuries in dogs, cats, and horses. We process stem cells from the animal's own fat tissue and deliver concentrated cells for veterinary injection. This patented approach has treated over 16,000 animals with documented efficacy in peer-reviewed studies.
PrecisePRP
PrecisePRP provides platelet-rich plasma therapy to enhance healing in orthopedic injuries for veterinary patients. We supply veterinarians with a standardized system to concentrate platelets from the patient's blood for targeted injection. This complementary regenerative modality supports tissue repair alongside stem cell treatments.
Steminsure
Steminsure offers long-term cryopreservation of adipose-derived stem cells for future therapeutic use in animals. We collect and process fat tissue during routine procedures to bank cells for potential future injuries or diseases. This proactive service ensures immediate access to autologous cells when needed.
Veterinary Services
We provide veterinarians with comprehensive regenerative medicine services including stem cell processing and platelet-rich plasma systems. Our partnership requires no capital investment or equipment maintenance while offering personalized veterinary, marketing, and customer support. Over 16,000 animals have been treated through our collaborative veterinary network.
